TipRanks on MSN

ACADIA Pharmaceuticals Advances Phase 2 Study of ACP-204 for Lewy Body Dementia Psychosis

ACADIA Pharmaceuticals Inc. (($ACAD)) announced an update on their ongoing clinical study. Study Overview: ACADIA Pharmaceuticals Inc. is ...

CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley

Mr. Quigley most recently led McKinsey & Company’s Private Capital practice and previously led various Life Sciences practices at the firm Appointment adds deep business strategy, transactional, and ...
TipRanks on MSN

CervoMed appoints Quigley to board of directors

CervoMed (CRVO) announced the appointment of David Quigley to its Board of Directors. Quigley is a seasoned executive and former Senior Partner at ...